In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HeartPort's Quiet Exit

Executive Summary

In the mid 1990's, many industry executives believed HeartPort Inc. was going to lead a revolution in cardiac minimally-invasive surgery. But the minimally-invasive cardiac surgery market has evolved in a different path than anyone, including many companies other than HeartPort, envisioned a decade ago. In the end, the broader vision of a transforming technology failed to materialize for HeartPort. Ethicon recently purchased the company for $81 million.
Advertisement

Related Content

HeartFlow: Disrupting The Diagnostic Paradigm In Cardiology
HeartFlow: Disrupting The Diagnostic Paradigm In Cardiology
Cardica: Rebuilding the Cardiac Surgery Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel